NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Jun 30, 2018
Filed with the SEC on Aug 13, 2018 and accepted by EDGAR at Aug 13, 2018, 20:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2018-04-01 to 2018-06-30 | $225.5k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2018-01-01 to 2018-06-30 | $330.6k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2018-04-01 to 2018-06-30 | −$1.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-01-01 to 2018-06-30 | −$2.3m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2018-04-01 to 2018-06-30 | −$1.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months2018-01-01 to 2018-06-30 | −$2.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-04-01 to 2018-06-30 | −$0.16 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2018-01-01 to 2018-06-30 | −$0.33 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months2018-01-01 to 2018-06-30 | −$1.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Current assets | At period end2018-06-30 | $23.2k | us-gaap:AssetsCurrent |
| Total assets | At period end2018-06-30 | $229.7k | us-gaap:Assets |
| Current liabilities | At period end2018-06-30 | $3.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-06-30 | $7.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-06-30 | −$7.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-18-010817. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.